The Lynx Group
Encore Presentation:

COVID-19 Impact on the Cancer Care Delivery Ecosystem

A discussion articulating the challenges facing cancer care in the current COVID-19 crisis by some of the top thought leaders, faculty, and key opinion leaders.

We hope that you can join us for this important and informative event.

The event is free to all who are interested; however, we are accepting donations to offset the cost of the event with any additional proceeds to directly fund the efforts of first responders and front-line healthcare professionals working tirelessly to save lives during this time of national crisis. Tax deductible donations can be made through the AONN+ Foundation for Learning, a 501(c)(3) organization.

  • Thursday, April 9, 2020
    5:30 pm – 8:00 pm EDT

  • Welcome and Opening Remarks
    Washington and Public Policy
    Managed Care Payers
    Community Cancer Care Providers
    Comprehensive Cancer Care Systems
    Wholesale Supply Channel
    Pharmaceutical Manufacturers
    Oncology Nursing and Cancer Care
    Patient Advocacy
    Oncology Pharmacy
    Revenue Cycle Management
    Longer-Term Impact
    Closing Comments
    • Burt Zweigenhaft, PhD, DLitt
      Founder, Association for Value-Based Cancer Care
    • Clifford Hudis, MD, FACP, FASCO
      CEO, American Society of Clinical Oncology
    • Jayson Slotnik, JD, MPH
      Managing Partner, Health Policy Strategies
    • Steven Peskin, MD, MBA, FACP
      Executive Medical Director of Population Health and Transformation, Horizon BCBS
    • Scott Breidbart, MD, MBA
      Chief Medical Officer, Affinity Health Plan
    • Matthew Eyles
      President & CEO, America’s Health Insurance Plans (AHIP)
    • Barry Fortner, PhD
      President, Specialty Physician Services, AmerisourceBergen
    • Brian Morrissey, VP
      Strategic Customer Group Oncology, Pfizer
    • Ted Okon, MBA
      Executive Director, Community Oncology Alliance
    • Jeff Patton, MD
      President, Tennessee Oncology
    • Lucio Gordan, MD
      President, Florida Cancer Specialists; President, American Oncology Partners
    • Robert Carlson, CEO
      National Comprehensive Cancer Network
    • Pat Basu, MD, MBA
      President & CEO, Cancer Treatment Centers of America Global
    • Christian Downs, MHA, JD
      Executive Director, Association of Community Cancer Centers
    • Michael Reff, RPh, MBA
      President, National Community Oncology Dispensing Association
    • Lillie Shockney, RN, BS, MAS, HON-ONN-CG
      Founder, Academy of Oncology Nurse & Patient Navigators
    • Brenda Nevidjon, MSN, RN, FAAN, CEO
      Oncology Nursing Society
    • Brian Gockerman, MBA
      Managing Director, Unlimited Technology Systems
    • Parag Shah
      President, Practice Solutions, Integra Connect
    • Trish Goldsmith
      CEO, CancerCare
    • Daniel Klein
      President & CEO, Patient Access Network Foundation
    • Pete Perron, MS
      President, Provider Solutions, McKesson
    • Don McDaniel, MBA
      CEO, Canton & Company
    • Michael Consuelos, MD, MBA, FAAP
      Principal, MJC Solutions; Former CMO, Hospital Association of Pennsylvania
    • Julie Gerberding, MD, MPH
      Chief Patient Officer, Communications, Global Policy, and Population Health, Merck
    • Eric Dozier, MBA
      VP, North American Oncology, Lilly Oncology
    • Ray Bailey, BPharm, RPh
      Pharmacy Director, Florida Cancer Specialists
    • Tommy Pourmahram
      VP, Specialty Provider, McKesson
    • Scott Gottlieb, MD
      Former FDA Commissioner
    Note: Additional faculty members are continually being confirmed and only emergency situations will change the status of a confirmed faculty member.

Disclaimer: Funding from these donations to the AONN+ Foundation for Learning will not be used for certification purposes. These funds will solely cover the cost of the event, and all remaining proceeds will be donated to first responders and front-line healthcare professionals. By making a donation you are not entitled to any special benefits; a donation has no direct impact or influence on decisions on certification.

Personalized Medicine | Browse By Specialty

We Want to Know

Is access to care an obstacle for patients today?


Latest Videos

Effective Targeted Therapies in CCA: IDH1 and FGFR
Managing CCA Patients While Waiting for Molecular Biomarker Testing Results

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: